REQUEST A DEMO
Total
USD $0.00
Search more companies

GUP Bryanskfarmaciya (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: GUP Bryanskfarmaciya Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

GUP Bryanskfarmaciya is an enterprise based in Russia. Its main office is in Bryansk. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 31, 2014. There was a net sales revenue drop of 3.62% reported in GUP Bryanskfarmaciya’s latest financial highlights for 2022. There was a total growth of 8.62% in GUP Bryanskfarmaciya’s total assets over the same period. The net profit margin of GUP Bryanskfarmaciya decreased by 0.5% in 2022.

Headquarters
Stanke Dimitrova, 49A
Bryansk; Bryansk Oblast; Postal Code: 241050

Contact Details: Purchase the GUP Bryanskfarmaciya report to view the information.

Website: http://bfarm.ru

Basic Information
Outstanding Shares:
Purchase the GUP Bryanskfarmaciya report to view the information.
Registered Capital:
Purchase the GUP Bryanskfarmaciya report to view the information.
Incorporation Date:
March 31, 2014
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Rusaseptika OOO
51%
Strahovaya Kompaniya Ecooms OAO
0.156%
Company Performance
Financial values in the chart are available after GUP Bryanskfarmaciya report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-3.62%
Total operating revenue
-3.62%
Operating profit (EBIT)
-39.29%
Net Profit (Loss) for the Period
-70.44%
Total assets
8.62%
Total equity
-7.2%
Operating Profit Margin (ROS)
-0.42%
Net Profit Margin
-0.5%
Return on Equity (ROE)
-23.16%
Quick Ratio
0.07%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?